Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

FDA warns India’s Emcure Pharma, cites repeated data fudging at plant

The U.S. Food and Drug Administration (FDA) has warned Indian generic drugmaker Emcure Pharmaceuticals, saying it repeatedly fudged test records at its plant in western India, in another case of a pharmaceutical firm in the country facing such action.   In a letter, the FDA said its staff inspected Emcure’s plant at Hinjwadi, Pune, where […]

Read More »

New technology chief joins Palio; Saratoga office to wind down

Changes are taking place at Palio. The agency will be shutting down its Saratoga, N.Y., office by the end of June and consolidating business in its New York City and Los Angeles offices. Additionally, the agency has appointed its first technology leader. As senior VP, director of technology, Bryan Roman will report to President Kim […]

Read More »

Study strengthens Zika-microcephaly link, women and babies at risk

Thousands of pregnant women caught in the outbreak of the mosquito-borne virus spreading from Brazil risk having a baby with the birth defect microcephaly, according to study results.

Read More »

Gilead Shuts Down Six Zydelig Trials Following EMA Review

Gilead Sciences halted six trials for its cancer drug Zydelig following concerns of adverse effects and deaths.

Read More »

E-Commerce: Its advancement and upcoming perspectives

The e-commerce could very well be described being a new home business methodology that addresses the demands of corporations, retailers, and people to chop expenses as bettering the standard of products and products and services and expanding the pace of company shipping and delivery, by utilizing The web. The event of electronic commerce evolved to […]

Read More »

UK’s Vectura Buys Skyepharma to Create Powerful Respiratory Company

Chippenham, UK-based Vectura Group plc announced that the company is acquiring Skyepharma plc of London in a deal worth $621 million.

Read More »

Allied-Bristol Life Sciences Launches ißeCa Therapeutics

Allied-Bristol Life Sciences announced a new subsidiary to license compounds from the NYU School of Medicine targeting the Wnt signaling pathway, which is implicated in various cancers.

Read More »

E-Commerce: Its growth and upcoming perspectives

The e-commerce tends to be outlined as the cutting-edge internet business methodology that addresses the specifications of companies, retailers, and people to cut expenses although increasing the standard of goods and solutions and boosting the velocity of program shipping, by making use of Internet. The development of digital commerce advanced as a means of growing […]

Read More »

E-Commerce: Its improvement and long term views

The e-commerce might be outlined like a modern-day industry methodology that addresses the needs of organizations, retailers, and customers to chop prices even while bettering the quality of products and services and expanding the pace of support shipping and delivery, by using Online world. The development of digital commerce evolved as being a strategy for […]

Read More »

Sanofi signs deal worth up to $2.3 billion with DiCE Molecules

French drugmaker Sanofi could pay privately held DiCE Molecules as much as $2.3 billion under a partnership deal announced on Wednesday that aims to find new oral medicines to replace injections for certain diseases.   The five-year research alliance involves Sanofi paying an initial $50 million to access DiCE’s technology and taking an equity stake […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom